Details

NameSymbolSector
COHANCE LIFESCIENCES LIMITEDCOHANCEPharmaceuticals
Open
460.45
High
467.35
Low
458.1
Close
464.05
Volume
763452
Exchange
nse
Time
16-Oct-2026

Outlook

Score:  

3.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Cohance Lifesciences is  
Short Body
Estimated Stoploss of Cohance Lifesciences is ₹  
458.1
Cohance Lifesciences has a  
Bullishℹ
 pattern. 
Formation of  
Short Body
 candle pattern indicates the trend direction of Cohance Lifesciences is  
Unpredictableℹ
. 

Trend

Cohance Lifesciences is in  
Sideways trendℹ
. 
Price of Cohance Lifesciences is  
Upℹ
 by  

3.7

%. 
Target
Buy @ 

420.92

Sell @ 

469.44

Current @ 

464.05

Volume

The trade volumes of Cohance Lifesciences have become  
Deficientℹ
Though the volume trend for Cohance Lifesciences appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Cohance Lifesciences is  

Down

 by  

20.68

% 

Valuation

The current market price of Cohance Lifesciences is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 3031cr and total assets worth ₹ 3031cr, the balance sheet of Cohance Lifesciences is:  
Balancedℹ
. 
Cashflow
Cohance Lifesciences has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 38cr

. It is  
Upℹ
 by  

323.53

%. 

(*Mar 2025)

52.65% i.e. ₹ 288cr earned in operatingℹ
46.62% i.e. ₹ 255cr spent in investingℹ
0.55% i.e. ₹ 3cr earned in financingℹ
0.18% i.e. ₹ 1cr earned in otherℹ
Cohance Lifesciences has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 17cr

. It is  
Downℹ
 by  

185

%. 

(*Mar 2024)

48.84% i.e. ₹ 358cr earned in operatingℹ
49.39% i.e. ₹ 362cr spent in investingℹ
1.77% i.e. ₹ 13cr spent in financingℹ
0% in otherℹ
Income
The income of Cohance Lifesciences is  

₹ 571cr

 and  

Profit

 is :  

₹ 66cr

(*Sep 2025)

Cohance Lifesciences Profit is up by:  

21.05

% and Income is Up by:  

36.65

% 

(*Sep 2025)

The income of Cohance Lifesciences is  

₹ 563cr

 and  

Profit

 is :  

₹ 46cr

(*Jun 2025)

Cohance Lifesciences Profit is down by:  

54.22

% and Income is Up by:  

27.95

% 

(*Jun 2025)

The income of Cohance Lifesciences is  

₹ 412cr

 and  

Profit

 is :  

₹ 38cr

(*Mar 2025)

Cohance Lifesciences Profit is up by:  

2.47

% and Income is Up by:  

18.82

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.